Aubagio teriflunomide regulatory update

Australia's Therapeutic Goods Administration ( TGA) approved once-daily, oral Aubagio teriflunomide from Sanofi to treat relapsing forms of multiple sclerosis (MS). The pharma said Aubagio is now mark...